Ultragenyx
RARE
$44.28
Share price
-1.84%
Change (1 day)
1.54%
Change (1 year)
Categories
Operating Margin for Ultragenyx (RARE)
Operating Margin as of April 2024 (TTM): -162.16%
According to Ultragenyx's latest financial reports and stock price the company's current Operating Margin is -162.16%. At the end of 2022 the company had an Operating Margin of -193.14%.
Operating Margin history for Ultragenyx from 2017 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -193.14% | 49.83% |
| 2021 | -128.91% | 88.48% |
| 2020 | -68.39% | -82.24% |
| 2019 | -385.14% | 0.62% |
| 2018 | -382.75% | -96.86% |
| 2017 | -12,187.52% | -93.41% |
| 2016 | -184,841.35% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Lexicon Pharmaceuticals
LXRX | -87,620.60% | 53,933.42% | 🇺🇸 USA |
 Esperion Therapeutics ESPR | -343.04% | 111.54% | 🇺🇸 USA |
 Amicus Therapeutics
FOLD | -55.07% | -66.04% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | 4.83% | -102.98% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.